A recent post hoc analysis published in The Journal of Rheumatology showed that TOF significantly improved efficacy compared to placebo across various baseline CRP levels. …
A recent Phase 2 clinical trial, published in the Annals of Rheumatic Diseases, has revealed encouraging results for remibrutinib, an experimental drug, in treating moderate-to-severe …
Primary Sjögren’s syndrome (pSS), characterized by lymphocyte infiltration into exocrine glands, poses significant challenges due to its heterogeneous presentation and overlap with other autoimmune diseases. …
Riociguat is primarily indicated for the management of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). A recent phase 2b RISE-SSc trial, published …
A recent study published in the New England Journal of Medicine revealed that once-weekly injections of semaglutide significantly reduced both body weight and knee pain …
Groundbreaking research published in Life Science Alliance unveiled BTB domain and CNC homology 1 (BACH1) as a master regulator of destructive cell behavior in rheumatoid …
In a groundbreaking systematic review and meta-analysis, researchers revealed compelling evidence supporting the efficacy and safety profile of iguratimod (IGU) in treating ankylosing spondylitis (AS). …
A recent study published in the Rheumatic and Musculoskeletal Diseases Open has highlighted the potential role of specific serum biomarker ratios in enhancing diagnostic accuracy …
A groundbreaking study published in International Immunopharmacology has revealed that serum levels of High Mobility Group Box Protein-1 (HMGB-1), a multifunctional protein, could serve as …